2[2]Slogoff S, Reul GJ, Keats AS, et al. Role of perfusion pressure and flow in major organ dysfunction after cardiopulmonary bypass. Ann Thorac Surg, 1990, 50:911-918.
3[3]Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. J Thorac Cardiovasc Surg, 1994, 107: 1489-1495.
4[4]Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med, 1998, 104:343-348.
5[5]Schmitt H, Riehl J, Boseila A, et al. Acute renal failure following cardiac surgery: pre-and peri-operative clinical features. Contrib Nephrol, 1991, 93:98-104.
6[6]Suen WS, Mok CK, Chiu SW, et al. Risk factors for development of acute renal failure requiring dialysis in patients undergoing cardiac surgery. Angiology, 1998, 49:789-800.
7[7]Thadhani R, Pascual M, Bonventre JV, et al. Actue renal failure. N Engl J Med, 1996, 334:1448-1460.
8[8]Sirivella S, Gielchinsky I, Parsonnet V, et al. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg, 2000, 69:501-506.
9[9]Lanze HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J, 1987, 113:1138-1143.
10[10]Ebadi M. Diuresis. In: Ebadi M, ets. Pharmacology. 2nd ed. Boston: Little Brown, 1993, 227-239.
1Wald R, Liangos O, Perianayagam MC, et al. Plasma cystatin C and acute kidney injury after cardiopuhnonary bypass, Clin J Am Soc Nephrol, 2010,5(8): 1373- I379.
2Baskin E, Gulleroglu KS, Saygili A, et al. Peritoneal dialysis requirements following open-heart surgery in children with congenital heart disease. Ren Fail, 2010(7 ): 784-787.
3Uchino S, BeUomo R, Goldsmith D,et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Cave Med, 2006,34(7) :2016-2017.
4Allan CK, Newburger JW, McGrath E, et al. The relationship between inflammatory activation and clinical outcome after infant carcliopulmonary bypass. Anesth Annlg, 2010,111 (5): 1244-1251.
5Haase M, Beilomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the.role of labile iron toxicity in cardiopulmonary bypassassociated acute kidney injury, J Am Coll Cardiol,2010,55 (19): 2024-2033.
6Liang XL, Liu SX, Chert YH, et al. Combination of urinary kidney injury molecule- 1 and interleukin- 18 as early biomarker for the diagnesis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case - control study. Biomarkers, 2010,15(4) : 332-339.
7Liangos O, Kolyada A, Tighiouart H, et al. Interleukin- 8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study. Nephron Clin Praet, 2009,113(3): 148-154.
8Patrick MH,Olivier JB,Willem B, et al.High-volume hemofiltration in sepsis and SIRS:current concepts and future prospects.Blood Purif,2009,28:1-11.
9McCarthy A, Shaban R, Boys J, et al.Compliance, normality, and the patient on peritoneal dialysis. Nephrol Nuts J,2010, 37 (3) : 243- 250.
